Denemek ALTIN - Özgür
Donald Trump, unbowed, is enacting change on scale rarely seen before
Mint Hyderabad
|April 08, 2025
And it's only been 77 days. No American president has disrupted so many aspects of the nation's daily life as President Trump has in less than three months in office.
His no-apologies agenda has made him the focal point of crucial decisions now being made in America's C-suites, on factory floors, in faculty lounges, elementary-school libraries and capitals around the world—as well as around kitchen tables across the U.S.
He has moved with astonishing speed to enact an immigration crackdown, cut the federal workforce and demolish federal agencies. He is checking off a list of perceived enemies, firing people at will and slashing at major law firms that some advisers allege once aided investigations into his actions. Asserting a broad mandate, Trump has worked with little regard for public criticism. In typical is-he-serious-or-not form, Trump now flirts with seeking a third term.
"He's going after all these targets with a sense of presidential power that is unbound," said Princeton historian Julian Zelizer. "Where this goes next is a mystery."
In many ways Trump is doing what he said he would on the campaign trail, and aspects of his agenda, including deportations, have broad public appeal. But the collective impact has been dizzying for many.
Trump's tariffs—an effort to reshape the global trading system—have put many Americans in a defensive pose as they decide how to handle the likelihood of higher prices and a rout in the market that wiped out $6.6 trillion in market value last week. Foreign governments are deciding whether to fight or negotiate new tariffs or accede. America's allies and adversaries are reviewing their military spending as they consider a world in which Trump uses America's military and economic muscle to squeeze every advantage from other countries at the expense of U.S. alliances.
Bu hikaye Mint Hyderabad dergisinin April 08, 2025 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Mint Hyderabad'den DAHA FAZLA HİKAYE
Mint Hyderabad
MakeMyTrip hiring banks for India IPO
MakeMyTrip Ltd, an online travel platform listed on the Nasdaq, is considering a listing in Mumbai, people familiar with the matter said.
1 min
April 30, 2026
Mint Hyderabad
Decoding Sebi’s broker net worth plan
The Securities and Exchange Board of India (Sebi) has proposed changes to the way variable net worth is calculated for stockbrokers.
2 mins
April 30, 2026
Mint Hyderabad
The 0.01 trap: India's GDP must not remain aloof from its people
We face a structural crisis in the collapse of formal job elasticity. Rapid economic growth must spell better lives for everyone
4 mins
April 30, 2026
Mint Hyderabad
Why rate cuts don't benefit every home loan borrower
Many lenders adjust loan tenure instead of EMIs, quietly increasing the total interest paid
4 mins
April 30, 2026
Mint Hyderabad
Piramal Pharma bets big on complex therapies
India’s Piramal Pharma hopes to accelerate earnings growth over the next two to three years, led by rising demand for complex drugs, including targeted cancer therapies, a top executive said on Wednesday.
1 min
April 30, 2026
Mint Hyderabad
Servify scouts for acquisitions ahead of filing for IPO
Smartphone care and warranty provider Servify is looking to close a string of acquisitions to expand its service categories before it files papers for a public listing.
1 mins
April 30, 2026
Mint Hyderabad
Vedanta FY26 earnings tops estimates ahead of its split
Vedanta reported FY26 revenue of ₹1.74 trillion, up 15.8% year-on-year, beating estimates
3 mins
April 30, 2026
Mint Hyderabad
Centre plans ring roads, elevated corridors to unclog urban India
The Union road transport and highways ministry is recalibrating its highbuilding strategy to focus on decongesting urban India, with plans to prioritize ring roads and bypass corridors around nearly 50 cities with populations exceeding one million, two people aware of the development said.
2 mins
April 30, 2026
Mint Hyderabad
Canada nod for DRL's GLP-1 shot
Dr Reddy's Laboratories (DRL) on Wednesday said it has received a notice of compliance (NoC) from Health Canada for its generic semaglutide injection indicated for the management of type-2 diabetes.
1 min
April 30, 2026
Mint Hyderabad
The UAE’s departure from OPEC may not break the cartel
WHEN THE Organisation of the Petroleum Exporting Countries (OPEC) meets on April 29th, the club will be contemplating the departure of one of its longest-standing members.
3 mins
April 30, 2026
Listen
Translate
Change font size

